TABLE 1.

Study demographics and objective response to therapeutic intervention

Dog ID	Age (years)	Sex	Breed	Tumor location	Glioma subclassification	Grade	Trialb	Time to maximal response (months)	Maximal response (%)	Objective response
1	7	FS	Boxer	Parietal	Oligodendroglioma	High	1A	3	−58	Stable
2	8	MI	Boxer	Temporal	Astrocytoma	Low	1A	3	−18	Stable
3	8	FS	Boxer	Temporal	Oligodendroglioma	Low	1A	3	−44	Stable
4a	8	MC	English Bulldog	Parietal	Oligodendroglioma	High	1A	0	Progression	Progression
5	5	MC	French bulldog	Frontal, Parietal	Oligodendroglioma	High	1B	3	−28	Stable
6	6	FS	Mixed	Parietal, Occipital	Oligodendroglioma	High	1B	3	+43	Progression
7	9	MC	Boston Terrier	Temporal	Oligodendroglioma	High	1B	6	−92	Partial
8	8	MI	Swiss Mountain	Parietal	Astrocytoma	Low	1B	3	−60	Stable
9	8	FS	Boxer	Right Pyriform	Oligodendroglioma	High	1B	6	−88	Partial
10	8	MC	Boxer	Right Pyriform	Oligodendroglioma	Low	1B	3	−9	Stable

^aDenotes the dog succumbed to disease before follow-up MRI.

^bTrial 1A dogs had a postmortem histological diagnosis, while 1B received a biopsy pre-enrollment to confirm the diagnosis.